Abivax (ABVX) Cash from Investing Activities (2024 - 2026)

Abivax's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at $579519.1 for Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 49.08% year-over-year to $579519.1 in Q1 2026; TTM through Mar 2026 was -$10.2 million, a 163.3% decrease from a year earlier, with the FY2025 full-year figure at -$9.5 million, down 155.82% from the prior year.
• Cash from Investing Activities advanced to $579519.1 in Q1 2026 per ABVX's latest filing, from -$14.8 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $12.4 million in Q2 2024 and bottomed at -$14.8 million in Q4 2025.
• The 3-year median for Cash from Investing Activities is $1.1 million (2025), against an average of $887626.8.
• Biggest YoY gain for Cash from Investing Activities was 99.75% in 2025; the steepest drop was 2438.01% in 2025.
• Year by year, Cash from Investing Activities stood at $634745.7 in 2024, then plunged by 2438.01% to -$14.8 million in 2025, then surged by 103.91% to $579519.1 in 2026.
• Per Business Quant, the three latest ABVX Cash from Investing Activities figures stand at $579519.1 (Q1 2026), -$14.8 million (Q4 2025), and $3.8 million (Q3 2025).